Nguyen T et al: Surgery versus stereotactic radiosurgery for the treatment of multiple meningiomas in neurofibromatosis type 2: illustrative case and systematic review. Neurosurg Rev. 42(1):85-96, 2019
Sverak P et al: Bevacizumab for hearing preservation in neurofibromatosis type 2: Emphasis on patient-reported outcomes and toxicities. Otolaryngol Head Neck Surg. 160(3):526-32, 2019
Kaul V et al: Management of vestibular schwannoma (including NF2): facial nerve considerations. Otolaryngol Clin North Am. 51(6):1193-212, 2018
Morris KA et al: Comparing the sensitivity of linear and volumetric MRI measurements to detect changes in the size of vestibular schwannomas in patients with neurofibromatosis type 2 on bevacizumab treatment. Br J Radiol. 89(1065):20160110, 2016
Evans DG et al: Bilateral vestibular schwannomas in older patients: NF2 or chance? J Med Genet. ePub, 2015
Jethanamest D et al: Conservative management of vestibular schwannoma: Predictors of growth and hearing. Laryngoscope. ePub, 2015
Ferner RE et al: Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2. J Neurol. 261(5):963-9, 2014
Giovannini M et al: mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma. Neuro Oncol. 16(4):493-504, 2014
Matsuo M et al: Characterization of early onset neurofibromatosis type 2. Brain Dev. 36(2):148-52, 2014
Plotkin SR et al: Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients. Otol Neurotol. 35(1):e50-6, 2014
Vargas WS et al: Incidental parenchymal magnetic resonance imaging findings in the brains of patients with neurofibromatosis type 2. Neuroimage Clin. 4:258-65, 2014
Goutagny S et al: Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro Oncol. 14(8):1090-6, 2012
Hanemann CO: Magic but treatable? Tumours due to loss of merlin. Brain. 131(Pt 3):606-15, 2008
Fisher LM et al: Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2. Otol Neurotol. 28(8):1083-90, 2007
Bosch MM et al: Optic nerve sheath meningiomas in patients with neurofibromatosis type 2. Arch Ophthalmol. 124(3):379-85, 2006
Omeis I et al: Meningioangiomatosis associated with neurofibromatosis: report of 2 cases in a single family and review of the literature. Surg Neurol. 65(6):595-603, 2006
Neff BA et al: Current concepts in the evaluation and treatment of neurofibromatosis type II. Otolaryngol Clin North Am. 38(4):671-84, ix, 2005
Ruggieri M et al: Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics. 36(1):21-34, 2005
Otsuka G et al: Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2. J Neurosurg. 99(3):480-3, 2003
Related Anatomy
Loading...
Related Differential Diagnoses
Loading...
References
Tables
Tables
KEY FACTS
Terminology
Imaging
Top Differential Diagnoses
Pathology
Clinical Issues
Diagnostic Checklist
TERMINOLOGY
Abbreviations
Neurofibromatosis type 2 (NF2)
Synonyms
Acoustic neurofibromatosis, central neurofibromatosis
Multiple intracranial schwannomas, meningiomas, and ependymomas (MISME)
Nguyen T et al: Surgery versus stereotactic radiosurgery for the treatment of multiple meningiomas in neurofibromatosis type 2: illustrative case and systematic review. Neurosurg Rev. 42(1):85-96, 2019
Sverak P et al: Bevacizumab for hearing preservation in neurofibromatosis type 2: Emphasis on patient-reported outcomes and toxicities. Otolaryngol Head Neck Surg. 160(3):526-32, 2019
Kaul V et al: Management of vestibular schwannoma (including NF2): facial nerve considerations. Otolaryngol Clin North Am. 51(6):1193-212, 2018
Morris KA et al: Comparing the sensitivity of linear and volumetric MRI measurements to detect changes in the size of vestibular schwannomas in patients with neurofibromatosis type 2 on bevacizumab treatment. Br J Radiol. 89(1065):20160110, 2016
Evans DG et al: Bilateral vestibular schwannomas in older patients: NF2 or chance? J Med Genet. ePub, 2015
Jethanamest D et al: Conservative management of vestibular schwannoma: Predictors of growth and hearing. Laryngoscope. ePub, 2015
Ferner RE et al: Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2. J Neurol. 261(5):963-9, 2014
Giovannini M et al: mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma. Neuro Oncol. 16(4):493-504, 2014
Matsuo M et al: Characterization of early onset neurofibromatosis type 2. Brain Dev. 36(2):148-52, 2014
Plotkin SR et al: Natural history of vestibular schwannoma growth and hearing decline in newly diagnosed neurofibromatosis type 2 patients. Otol Neurotol. 35(1):e50-6, 2014
Vargas WS et al: Incidental parenchymal magnetic resonance imaging findings in the brains of patients with neurofibromatosis type 2. Neuroimage Clin. 4:258-65, 2014
Goutagny S et al: Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro Oncol. 14(8):1090-6, 2012
Hanemann CO: Magic but treatable? Tumours due to loss of merlin. Brain. 131(Pt 3):606-15, 2008
Fisher LM et al: Distribution of nonvestibular cranial nerve schwannomas in neurofibromatosis 2. Otol Neurotol. 28(8):1083-90, 2007
Bosch MM et al: Optic nerve sheath meningiomas in patients with neurofibromatosis type 2. Arch Ophthalmol. 124(3):379-85, 2006
Omeis I et al: Meningioangiomatosis associated with neurofibromatosis: report of 2 cases in a single family and review of the literature. Surg Neurol. 65(6):595-603, 2006
Neff BA et al: Current concepts in the evaluation and treatment of neurofibromatosis type II. Otolaryngol Clin North Am. 38(4):671-84, ix, 2005
Ruggieri M et al: Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: a study of 24 patients. Neuropediatrics. 36(1):21-34, 2005
Otsuka G et al: Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2. J Neurosurg. 99(3):480-3, 2003
STATdx includes over 200,000 searchable images, including x-ray, CT, MR, and ultrasound images. To access all images, please log in or subscribe.